Krebs Biochemicals & Industries Limited (BOM:524518)
India · Delayed Price · Currency is INR 75.85
+3.10 (4.26%)
At close: Sep 10, 2025
BOM:524518 Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Net Income | -269.39 | -197.28 | -246.92 | -445.27 | -283.59 | Upgrade |
Depreciation & Amortization | 65.05 | 65.82 | 63.75 | 56.58 | 48.64 | Upgrade |
Other Amortization | 1.84 | 1.84 | 1.84 | 6.39 | 2.6 | Upgrade |
Loss (Gain) From Sale of Assets | -1.22 | - | - | - | - | Upgrade |
Other Operating Activities | 58.42 | 51.18 | 32.59 | 51.14 | 65.52 | Upgrade |
Change in Accounts Receivable | 18.53 | -13.78 | 3.51 | -5.77 | -0.98 | Upgrade |
Change in Inventory | 37.65 | 21.49 | 136.17 | -89.62 | -16.05 | Upgrade |
Change in Accounts Payable | -8.18 | 36.89 | -226.26 | 171.3 | -18.71 | Upgrade |
Change in Other Net Operating Assets | 18.38 | 57.49 | -11.81 | 83.09 | 56.82 | Upgrade |
Operating Cash Flow | -78.91 | 23.65 | -247.13 | -172.16 | -145.75 | Upgrade |
Capital Expenditures | -35.63 | -94.15 | -151.58 | -270.78 | -255.06 | Upgrade |
Sale of Property, Plant & Equipment | 1.64 | 20.88 | - | - | - | Upgrade |
Other Investing Activities | -15.7 | -4.89 | 25.13 | 41.79 | 29.57 | Upgrade |
Investing Cash Flow | -49.7 | -78.17 | -126.45 | -229 | -225.49 | Upgrade |
Short-Term Debt Issued | 410.29 | - | - | - | - | Upgrade |
Long-Term Debt Issued | - | 102.54 | 403.17 | 323.84 | 334.91 | Upgrade |
Total Debt Issued | 410.29 | 102.54 | 403.17 | 323.84 | 334.91 | Upgrade |
Short-Term Debt Repaid | - | -0.61 | - | - | - | Upgrade |
Long-Term Debt Repaid | -222.5 | - | - | - | - | Upgrade |
Total Debt Repaid | -222.5 | -0.61 | - | - | - | Upgrade |
Net Debt Issued (Repaid) | 187.79 | 101.93 | 403.17 | 323.84 | 334.91 | Upgrade |
Issuance of Common Stock | - | - | - | 125.13 | 104.49 | Upgrade |
Other Financing Activities | -59.14 | -46.89 | -29.73 | -53.91 | -62.79 | Upgrade |
Financing Cash Flow | 128.65 | 55.03 | 373.43 | 395.06 | 376.61 | Upgrade |
Miscellaneous Cash Flow Adjustments | - | 0 | 0 | - | - | Upgrade |
Net Cash Flow | 0.04 | 0.52 | -0.15 | -6.1 | 5.36 | Upgrade |
Free Cash Flow | -114.54 | -70.5 | -398.71 | -442.95 | -400.81 | Upgrade |
Free Cash Flow Margin | -26.45% | -13.98% | -76.48% | -74.19% | -76.08% | Upgrade |
Free Cash Flow Per Share | -5.31 | -3.27 | -18.49 | -20.54 | -20.43 | Upgrade |
Cash Interest Paid | 59.08 | 46.86 | 29.71 | 53.85 | 62.72 | Upgrade |
Cash Income Tax Paid | 0.15 | - | - | - | - | Upgrade |
Levered Free Cash Flow | -57.76 | -37.27 | -336.06 | -332.22 | -449.94 | Upgrade |
Unlevered Free Cash Flow | -20.84 | -7.98 | -317.49 | -298.57 | -410.75 | Upgrade |
Change in Working Capital | 66.39 | 102.1 | -98.38 | 159 | 21.08 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.